Literature DB >> 2462755

Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.

K B Leung1, K C Flint, J Brostoff, B N Hudspith, N M Johnson, H Y Lau, W L Liu, F L Pearce.   

Abstract

Sodium cromoglycate and nedocromil sodium produced a dose dependent inhibition of histamine secretion from human pulmonary mast cells obtained by bronchoalveolar lavage and by enzymatic dissociation of lung parenchyma. Both compounds were significantly more active against the lavage cells than against the dispersed lung cells, and nedocromil sodium was an order of magnitude more effective than sodium cromoglycate against both cell types. Tachyphylaxis was observed with the parenchymal cells but not with the lavage cells. Nedocromil sodium and sodium cromoglycate also inhibited histamine release from the lavage cells of patients with sarcoidosis and extrinsic asthma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462755      PMCID: PMC461499          DOI: 10.1136/thx.43.10.756

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

Review 1.  On the heterogeneity of mast cells.

Authors:  F L Pearce
Journal:  Pharmacology       Date:  1986       Impact factor: 2.547

2.  Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction.

Authors:  K C Flint; K B Leung; B N Hudspith; J Brostoff; F L Pearce; N M Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

3.  Functional characteristics of mucosal and connective tissue mast cells of man, the rat and other animals.

Authors:  F L Pearce; H Ali; K E Barrett; A D Befus; J Bienenstock; J Brostoff; M Ennis; K C Flint; B Hudspith; N M Johnson
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

Review 4.  Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma.

Authors:  C Robinson; S T Holgate
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

5.  Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate.

Authors:  K C Flint; K B Leung; F L Pearce; B N Hudspith; J Brostoff; N M Johnson
Journal:  Clin Sci (Lond)       Date:  1985-04       Impact factor: 6.124

Review 6.  Mast cell heterogeneity: derivation and function, with emphasis on the intestine.

Authors:  J Bienenstock; A D Befus; F Pearce; J Denburg; R Goodacre
Journal:  J Allergy Clin Immunol       Date:  1982-12       Impact factor: 10.793

Review 7.  Calcium and histamine secretion from mast cells.

Authors:  F L Pearce
Journal:  Prog Med Chem       Date:  1982

8.  Inhibition by disodium cromoglycate of anaphylactic histamine secretion from rat peritoneal mast cells in the presence of phosphatidylserine.

Authors:  F L Pearce; E Rafii-Tabar
Journal:  Agents Actions       Date:  1983-04

9.  The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine.

Authors:  M K Church; K D Young
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

10.  The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey.

Authors:  R P Eady; B Greenwood; D M Jackson; T S Orr; E Wells
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

View more
  14 in total

1.  Treatment of chronic asthma in children: the changing role of inhaled corticosteroids.

Authors:  D J Cook
Journal:  CMAJ       Date:  1992-05-15       Impact factor: 8.262

Review 2.  Long-term drug treatment of asthma in children.

Authors:  K F Kerrebijn
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  The actual role of sodium cromoglycate in the treatment of asthma--a critical review.

Authors:  Nikolaus C Netzer; T Küpper; Hans W Voss; Arn H Eliasson
Journal:  Sleep Breath       Date:  2012-01-06       Impact factor: 2.816

4.  Mast cells from human colonic mucosa and submucosa/muscle: a comparison with human lung mast cells.

Authors:  W L Liu; L Bosman; P B Boulos; H Y Lau; F L Pearce
Journal:  Agents Actions       Date:  1990-04

Review 5.  Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

6.  Effect of sodium metabisulphite on bronchial blood flow in conscious sheep: pharmacological modulation.

Authors:  G M Nichol; G H Parsons; K F Chung
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

7.  The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalation.

Authors:  Q A Summers; S Singh; R G Honeywell; A G Renwick; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 8.  New targets for modifying mast cell activation in asthma.

Authors:  Madeleine Ennis
Journal:  Curr Allergy Asthma Rep       Date:  2006-05       Impact factor: 4.919

Review 9.  The Anti-allergic Cromones: Past, Present, and Future.

Authors:  Ajantha Sinniah; Samia Yazid; Roderick J Flower
Journal:  Front Pharmacol       Date:  2017-11-14       Impact factor: 5.810

10.  Cromoglycate and nedocromil: influence on airway reactivity.

Authors:  E A Valletta; A L Boner
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.